Convergence in medicine Oslo Life Science 15 February 2018
-
Feb. 21, 2018
Predicting cancer evolution
Professor Trevor Graham, Barts Cancer Institute UK
-
Feb. 21, 2018
The convergence environment Personalised cancer therapies (PERCATHE) – background and the biostatistical perspectives
Professor Arnoldo Frigessi,Institute of Basic Medical Sciences, Faculty of Medicine, director of Oslo Centre for Biostatistics and Epidemiology (OCBE), UiO/OUS
-
Feb. 21, 2018
The convergence environment Personalised cancer therapies (PERCATHE) – the biological perspectives
Professor Kjetil Tasken, Director Centre for Molecular Medicine Norway (NCMM), the Faculty of Medicine, UiO. Head and Director of Institute for Cancer Research Oslo University Hospital (OUH)
-
Feb. 21, 2018
The convergence environment Personalised cancer therapies (PERCATHE) – the clinical perspectives
Åslaug Helland, Professor II, Institute of Clinical Medicine, Faculty of Medicine, UiO
-
Feb. 21, 2018
Dr. Peter Loskill: Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Germany
Stem cell based microphysiological Organ-on-a-Chip systems as in vitro models of human tissue
-
Feb. 21, 2018
The convergence environment Organ on a chip and nano-devices (CHIP) – background and the biological perspectives
Professor Stefan Krauss, Department of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, UiO, and Oslo University Hospital (OUS)
-
Feb. 21, 2018
The convergence environment Organ on a chip and nano-devices (CHIP) – the electronics perspective: Linear and non-linear electrical properties of biomaterials
Professor Ørjan Grøttem Martinsen, Department of Physics, Faculty of Mathematics and Natural Sciences
-
Feb. 21, 2018
The convergence environment Organ on a chip and nano-devices (CHIP) – the clinical perspectives
Dr. Hanne Scholtz, Division of surgery, inflammatory medicine and transplantation, OUS
-
Feb. 21, 2018
Preventing germline transmission of mitochondrial DNA mutations – therapeutic potential and ethical considerations
Professor Mary Herbert, Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, UK
The recording of this talk is not available
-
Feb. 21, 2018
The convergence environment Epigenetics and bioethics of human embryonic development – background and the biological perspectives
Professor II Arne Klungland, Institute of Basic Medical Sciences, Faculty of Medicine, UiO, and Clinic for Laboratory Medicine (KLM), Oslo University Hospital (OUS)
-
Feb. 21, 2018
The convergence environment Epigenetics and bioethics of human embryonic development – the ethical perspectives
Associate Professor, Anna Smajor, Department of Philosophy, Classics, History of Art and Ideas, Faculty of Humanities, UiO
-
Feb. 21, 2018
The convergence environment Epigenetics and bioethics of human embryonic development – the clinical perspectives
Professor II, Péter Fedorcsák, Institute of Clinical Medicine, Faculty of Medicine, UiO, and Department of Reproductive Medicine, OUS